Search Results - "VAN BEIJSTERVELDT, L"

Refine Results
  1. 1

    Longitudinal telomere length and body composition in healthy term-born infants during the first two years of life by de Fluiter, Kirsten S, Codd, Veryan, Denniff, Matthew, Kerkhof, Gerthe F, van Beijsterveldt, Inge A L P, Breij, Laura M, Samani, Nilesh J, Abrahamse-Berkeveld, Marieke, Hokken-Koelega, Anita C S

    Published in PloS one (02-02-2021)
    “…Leukocyte telomere length (LTL) is one of the markers of biological aging as shortening occurs over time. Shorter LTL has been associated with adiposity and a…”
    Get full text
    Journal Article
  2. 2

    Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours by Konings, I R H M, de Jonge, M J A, Burger, H, van der Gaast, A, van Beijsterveldt, L E C, Winkler, H, Verweij, J, Yuan, Z, Hellemans, P, Eskens, F A L M

    Published in British journal of cancer (28-09-2010)
    “…Background: JNJ-26483327 is an oral, potent, multi-targeted tyrosine kinase inhibitor, inhibiting kinases of epidermal growth factor receptor (EGFR)-1, -2 and…”
    Get full text
    Journal Article
  3. 3

    The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans by MANNENS, G. S. J, SNEL, C. A. W, VAN PEER, A, MEULDERMANS, W, HENDRICKX, J, VERHAEGHE, T, LE JEUNE, L, BODE, W, VAN BEIJSTERVELDT, L, LAVRIJSEN, K, LEEMPOELS, J, VAN OSSELAER, N

    Published in Drug metabolism and disposition (01-05-2002)
    “…Galantamine is a competitive acetylcholine esterase inhibitor with a beneficial therapeutic effect in patients with Alzheimer's disease. The metabolism and…”
    Get full text
    Journal Article
  4. 4

    Association Between Fat Mass in Early Life and Later Fat Mass Trajectories by de Fluiter, Kirsten S, van Beijsterveldt, Inge A L P, Breij, Laura M, Acton, Dennis, Hokken-Koelega, Anita C S

    Published in JAMA pediatrics (01-12-2020)
    “…A rapid increase in weight in early life is associated with an increased risk for adiposity and cardiovascular diseases at age 21 years and beyond. However,…”
    Get more information
    Journal Article
  5. 5

    Anthropometry‐based prediction of body composition in early infancy compared to air‐displacement plethysmography by Olga, Laurentya, Beijsterveldt, Inge A. L. P., Hughes, Ieuan A., Dunger, David B., Ong, Ken K., Hokken‐Koelega, Anita C. S., De Lucia Rolfe, Emanuella

    Published in Pediatric obesity (01-11-2021)
    “…Summary Background Anthropometry‐based equations are commonly used to estimate infant body composition. However, existing equations were designed for newborns…”
    Get full text
    Journal Article
  6. 6

    Intestinal uptake and biodistribution of novel polymeric micelles after oral administration by Mathot, Frédéric, van Beijsterveldt, L., Préat, V., Brewster, M., Ariën, A.

    Published in Journal of controlled release (10-03-2006)
    “…To determine the fate of polymeric micelles after oral administration, we investigated the possible transport of polymeric micelles across Caco-2 monolayers…”
    Get full text
    Journal Article
  7. 7

    Prenatal and Neonatal Characteristics of Children with Prader-Willi Syndrome by Grootjen, Lionne N, Uyl, Nathalie E M, van Beijsterveldt, Inge A L P, Damen, Layla, Kerkhof, Gerthe F, Hokken-Koelega, Anita C S

    Published in Journal of clinical medicine (28-01-2022)
    “…Prader-Willi syndrome (PWS) is a rare genetic syndrome with a wide spectrum of clinical features in early life. Late diagnoses are still present. We…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Strategies for absorption screening in drug discovery and development by Bohets, H, Annaert, P, Mannens, G, Van Beijsterveldt, L, Anciaux, K, Verboven, P, Meuldermans, W, Lavrijsen, K

    Published in Current topics in medicinal chemistry (01-11-2001)
    “…This review gives an overview of the current approaches to evaluate drug absorption potential in the different phases of drug discovery and development…”
    Get more information
    Journal Article
  11. 11

    Pharmacokinetic–pharmacodynamic modelling of fluvoxamine 5‐HT transporter occupancy in rat frontal cortex by Geldof, M, Freijer, J I, Van Beijsterveldt, L, Langlois, X, Danhof, M

    Published in British journal of pharmacology (01-07-2008)
    “…Background and purpose: The pharmacokinetic–pharmacodynamic (PK–PD) correlation of fluvoxamine 5‐HT transporter (SERT) occupancy was determined in rat frontal…”
    Get full text
    Journal Article
  12. 12

    Fat mass and fat‐free mass track from infancy to childhood: New insights in body composition programming in early life by Beijsterveldt, Inge A. L. P., Fluiter, Kirsten S., Breij, Laura M., Steen, Manouk, Hokken‐Koelega, Anita C. S.

    Published in Obesity (Silver Spring, Md.) (01-11-2021)
    “…Objective Early life is a critical window for adiposity programming. This study investigated whether fat mass percentage (FM%), fat mass index (FMI), abdominal…”
    Get full text
    Journal Article
  13. 13

    Poly- and perfluoroalkyl substances (PFAS) exposure through infant feeding in early life by van Beijsterveldt, Inge A.L.P., van Zelst, Bertrand D., de Fluiter, Kirsten S., van den Berg, Sjoerd A.A., van der Steen, Manouk, Hokken-Koelega, Anita C.S.

    Published in Environment international (01-06-2022)
    “…[Display omitted] •Human milk contains measurable amounts of PFOA and PFOS.•Daily PFAS intake is highest in exclusively breastfed infants of older…”
    Get full text
    Journal Article
  14. 14

    Early life poly- and perfluoroalkyl substance levels and adiposity in the first 2 years of life by van Beijsterveldt, Inge A L P, van Zelst, Bertrand D, Dorrepaal, Demi J, van den Berg, Sjoerd A A, Hokken-Koelega, Anita C S

    Published in European journal of endocrinology (30-03-2024)
    “…Poly- and perfluoroalkyl substances (PFASs) are nondegradable, man-made chemicals. They accumulate in humans with potential harmful effects, especially in…”
    Get full text
    Journal Article
  15. 15

    Longitudinal poly- and perfluoroalkyl substances (PFAS) levels in Dutch infants by van Beijsterveldt, Inge A.L.P., van Zelst, Bertrand D., van den Berg, Sjoerd A.A., de Fluiter, Kirsten S., van der Steen, Manouk, Hokken-Koelega, Anita C.S.

    Published in Environment international (01-02-2022)
    “…[Display omitted] •PFAS levels in infants at age 3 months predict levels at age 2 years.•2–3 fold higher levels in exclusive breastfed compared to formula fed…”
    Get full text
    Journal Article
  16. 16

    Body composition and bone mineral density by Dual Energy X-ray Absorptiometry: Reference values for young children by van Beijsterveldt, Inge A.L.P., van der Steen, Manouk, de Fluiter, Kirsten S., Spaans, Sander A.M.J., Hokken-Koelega, Anita C.S.

    Published in Clinical nutrition (Edinburgh, Scotland) (01-01-2022)
    “…Childhood obesity is a global public health threat, with an alarming rise in incidence. Obesity at young age has short-term and long-term morbidity. It is,…”
    Get full text
    Journal Article
  17. 17

    Longitudinal human milk macronutrients, body composition and infant appetite during early life by de Fluiter, Kirsten S., Kerkhof, Gerthe F., van Beijsterveldt, Inge A.L.P., Breij, Laura M., van de Heijning, Bert J.M., Abrahamse-Berkeveld, Marieke, Hokken-Koelega, Anita C.S.

    Published in Clinical nutrition (Edinburgh, Scotland) (01-05-2021)
    “…Breastfeeding is the gold standard infant feeding. Data on macronutrients in relation to longitudinal body composition and appetite are very scarce. The aim of…”
    Get full text
    Journal Article
  18. 18

    Skinfold-based-equations to assess longitudinal body composition in children from birth to age 5 years by van Beijsterveldt, Inge A.L.P., Dorrepaal, Demi J., de Fluiter, Kirsten S., de Ridder, Maria A.J., Hokken-Koelega, Anita C.S.

    Published in Clinical nutrition (Edinburgh, Scotland) (01-07-2023)
    “…In order to identify children at risk for excess adiposity, it is important to determine body composition longitudinally throughout childhood. However, most…”
    Get full text
    Journal Article
  19. 19

    Gastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog by Van Beijsterveldt, L E, Geerts, R J, Wuyts, K, Woestenborghs, R J, Meuldermans, W E, Heykants, J J

    Published in Drug metabolism and disposition (01-02-1995)
    “…Loperamide oxide is a prodrug of the effective antidiarrheal loperamide. Administration of this prodrug improves efficacy and tolerability. For better…”
    Get more information
    Journal Article
  20. 20

    Longitudinal body composition assessment in healthy term-born infants until 2 years of age using ADP and DXA with vacuum cushion by de Fluiter, Kirsten S., van Beijsterveldt, Inge A.L.P., Goedegebuure, Wesley J., Breij, Laura M., Spaans, Alexander M. J., Acton, Dennis, Hokken-Koelega, Anita C. S.

    Published in European journal of clinical nutrition (01-04-2020)
    “…Objectives Accelerated gain in fat mass (FM) in early life increases the risk for adult diseases. Longitudinal data on infant body composition are crucial for…”
    Get full text
    Journal Article